In this video my mom speaks on the events leading up to my cancer diagnosis as well as how she and my family have coped during the journey, supportive tips and advice.She’s also really funny so definitely worth a watch.Thank you once again everyone for all the support.
Michael Bishop, MD, University of Chicago, Chicago, IL, discusses results from the Phase III BELINDA trial (NCT03570892), which assessed tisagenlecleucel (tisa-cel), a chimeric antigen receptor (CAR) T-cell therapy, in patients with aggressive B-cell non-Hodgkin lymphoma. The primary endpoint, which was event-free survival, was not met, and tisa-cel was not superior to the current standard of care. Dr Bishop highlights the time taken for the therapy to be administered, bridging therapy, and the dosage of lymphodepleting chemotherapy to be factors affecting the trial results. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.
With Nationals just a few weeks away, Abby goes above and beyond to make sure she has the perfect team to bring home a trophy in this flashback from Season 7, Episode 9, “Battle of the Blondes.”#DanceMomsSubscribe for more from Dance Moms and other great Lifetime shows:https://mylt.tv/SubscribetoDanceMomsFind out more about the show and stream full episodes on our site:https://mylt.tv/DanceMomsClick here for more Dance Moms content! http://mylt.tv/DanceMomsYouTubeFollow Dance Moms on social media for the latest updates:Facebook: https://mylt.tv/DanceMomsFacebookInstagram: https://mylt.tv/DanceMomsInstagramTwitter: https://mylt.tv/DanceMomsTwitterCheck out exclusive Lifetime content:Website – https://mylt.tv/myLifetimeFacebook – https://mylt.tv/facebookTwitter – https://mylt.tv/twitter”Dance Moms” follows Abby Lee Miller and the nation’s favorite tween dancers as they take on Hollywood while new auditions, new competitions, and new studios raise the stakes.The road has not been easy for “Dance Mom’s” star Abby Lee Miller. After completing her prison sentence last year, the famed dance instructor was diagnosed with non-Hodgkin’s lymphoma. But if anything, Abby has proven she is a fighter and is not ready to hang up the dance shoes. The new season of Dance Moms follows Abby as she rebuilds her dance company while battling the after-effects of cancer that has left her confined to a wheelchair. Abby is ready to get back to her life and do what she loves most…teaching students to dance! With the goal of putting her life, health and dance studio back together, Abby returns to where it all began – the Abby Lee Dance Company in Pittsburgh.
Early PET response predicts outcome in large B-cell lymphoma patients treated with CD19 CAR-T by Dr. Musa Alzahrani (KSU) – 16-ICML Highlights – 08 Oct 2021
discusses early results of a phase 1/2 study evaluating subasumstat (TAK-981) in combination with rituximab in multiple subsets of CD20-positive relapsed/refractory non-Hodgkin lymphoma including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), follicular lymphoma (FL) and marginal zone lymphoma (MZL). The results of this study were recently presented at The American Society of Hematology Meeting & Exposition (ASH 2021).Subasumstat is an investigational, first-in-class small-molecule inhibitor of SUMOylation, which mediates cell cycle progression. In preclinical trials, subasumstat was shown to add synergistic benefit when combined with rituximab in non-Hodgkin lymphoma models.The phase 1/2 study is an ongoing clinical trial evaluating rituximab with increasing doses of subasumstat. The goal of the phase 1 portion is to establish safety and tolerability of subasumstat, namely the maximum tolerated dose and/or pharmacologically active dose. Data from the phase 1 portion were recently presented at ASH 2021. As of the data cutoff, 24 patients with CD20-positive relapsed/refractory non-Hodgkin lymphoma have been enrolled and treated, and an additional four patients are currently receiving treatment. Overall, subasumstat was well tolerated across dose levels with no dose-limiting toxicities reported to date. Transient flu-like symptoms such as fever, chills, fatigue, and diarrhea were common among patients, though these adverse events are easily manageable and typical of interferon therapies. Grade ≥3 treatment-emergent adverse events related to subasumstat were reported in two patients: grade 3 atrial fibrillation and grade 4 neutropenia. Additionally, the combination of subasumstat and rituximab resulted in promising clinical activity in patients with CD20-positive relapsed/refractory non-Hodgkin lymphoma, with an overall response rate of 29%. This supports the continued development of this combination in patients with non-Hodgkin lymphoma. The next steps for this study include: completing the phase 1 portion, establishing a recommended phase 2 dose, and opening the phase 2 expansion cohort in select indications such as DLBCL and FL. In addition, an ongoing phase 1b/2 study is currently evaluating subasumstat in combination with monoclonal antibodies (either subcutaneous daratumumab or mezagitamab) in patients with triple-class refractory multiple myeloma. Data from this trial was also recently presented at ASH 2021.
Football Fern and Melbourne City FC’s Rebekah Stott shares the story of her life and football career to date on and off the pitch, including her battle with Stage 3 Hodgkin’s lymphoma.
Jeremie Estegassy is a Stage 3 Hodgkin’s Lymphoma Survivor. He finished his last treatment in 2019, and now he is on his road to remission. Three years ago, he started losing his energy without any cause. But the rapid hair loss is what alarmed Jeremie, along with a nodule in the neck. Once he went to see the doctor, he immediately asked him to get admitted and did further tests. Once, Cancer was diagnosed, he underwent 12 rounds of chemotherapy as a part of the treatment. He started focusing more on his diet by avoiding more sugary and fast foods. He is grateful that he had a supportive family and friends throughout the cancer journey. Love Heals Cancer – Making quality integrative oncology cancer care accessible to all.Visit our Official website: https://lovehealscancer.org/Engage with Us!LinkedIn: https://www.linkedin.com/company/lovehealscancerofficial Facebook: https://www.facebook.com/lovehealscancerofficial/Instagram: https://www.instagram.com/lovehealscancerofficial/Twitter: https://twitter.com/lovehealscancerSubscribe on YouTube: http://bit.ly/SubscribeLHC
We are so happy to hear Howard Lutnick’s good news in his fight against non-Hodgkin’s lymphoma! Mazel tov!The Cantor Fitzgerald CEO talks his health and the state of the markets.
Minehut has partnered with the Leukemia and Lymphoma Society to raise awareness and funds in the fight against Blood Cancers! They put on a build competition and we had the privilege of checking out some of these builds, plus talk with some heroes about their journey!Donate Now at https://www.lls.org/buildCheck out Kate’s channel here!: https://www.youtube.com/c/helloiamkateNewest Strawburry17 video!: https://youtu.be/PkTrVMwVDk0Previous gaming video: https://youtu.be/ByTfEY-qu-MDiscord!: https://discord.gg/h43nypsEdited by: Lina https://twitter.com/linaamadrid|| NEW Strawburry17 Merchandise!! || http://sb17.co/shop| | | | | S t r a w b u r r y 1 7 | | | | |Website | http://bit.ly/sb17dotcomStrawburry17 | http://youtube.com/strawburry17Twitter | http://twitter.com/strawburry17Instagram | http://instagram.com/strawburry17Facebook | http://facebook.com/strawburry17Twitch | http://twitch.tv/strawburry17plays
In this session we present the most exciting results from our recent research efforts on Covid-19, cancer and rare diseases.
Oscar-winning actor, and Anthony Nolan Patron, Olivia Colman shares an emotional conversation with Holly Cross. Holly is a mum of two who did everything after her family’s lives were turned upside down when her son, Rupert, was diagnosed with a rare and acute blood disorder. We have released Holly and Olivia’s conversation to mark what would have been the 50th birthday of Anthony Nolan, the little boy our charity was named after. Unlike Holly’s son, Rupert, Anthony never found the matching donor he needed, and he died when he was just seven years old. His mother, Shirley pioneered and launched the world’s first stem cell register in 1974. Since then, Anthony’s story has given the hope of a lifesaving transplant to millions of people with blood cancer or a blood disorder across the world.